|
Volumn 55, Issue 12, 2000, Pages 921-928
|
Accuracy of axillary MR imaging in treated breast cancer for distinguishing between recurrent tumour and treatment effects: Does intravenous Gd-DTPA enhancement help in cases of diagnostic dilemma?
|
Author keywords
Breast neoplasms; Gadopentetate dimeglumine; Lymphatic system; MRI
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GADOLINIUM PENTETATE;
GADOLINIUM PENTETATE MEGLUMINE;
ADULT;
AGED;
ARTICLE;
AXILLARY LYMPH NODE;
BREAST CANCER;
CANCER SURGERY;
CLINICAL TRIAL;
CONTRAST ENHANCEMENT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
EVALUATION;
FEMALE;
FOLLOW UP;
HUMAN;
LYMPH NODE METASTASIS;
MAJOR CLINICAL STUDY;
METASTASIS;
MUSCLE ATROPHY;
MYOSITIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PECTORALIS MAJOR MUSCLE;
PRIORITY JOURNAL;
SENSITIVITY AND SPECIFICITY;
SOFT TISSUE;
SYMPTOM;
THYROID GLAND;
TREATMENT OUTCOME;
TREATMENT PLANNING;
TUMOR RECURRENCE;
|
EID: 0034522357
PISSN: 00099260
EISSN: None
Source Type: Journal
DOI: 10.1053/crad.2000.0553 Document Type: Article |
Times cited : (5)
|
References (27)
|